Genetics and immunodysfunction underlying Behçet’s disease and immunomodulant treatment approaches

Genetics and immunodysfunction underlying Behçet’s disease and immunomodulant treatment approaches


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: آرش سلمانی نژاد

کلمات کلیدی: Behc¸et’s disease; genetics; immunology; clinical; treatment

نشریه: 17804 , 1 , 14 , 2017

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله آرش سلمانی نژاد
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات کاربردی دارویی
کد مقاله 61075
عنوان فارسی مقاله Genetics and immunodysfunction underlying Behçet’s disease and immunomodulant treatment approaches
عنوان لاتین مقاله Genetics and immunodysfunction underlying Behçet’s disease and immunomodulant treatment approaches
ناشر 9
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ خیر
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت http://www.tandfonline.com/doi/full/10.1080/1547691X.2017.1346008

خلاصه مقاله
hide/show

Behc¸et’s disease (BD) is a chronic autoimmune condition primarily prevalent in populations along the Mediterranean Sea. The exact etiology of BD has not been fully explained yet, but the disease occurrence is associated with a genetic factor, human leukocyte antigen (HLA)-B51 antigen. Among the various immu- nodysfunctions that are found in BD, patients are increased neutrophil motility and superoxide produc- tion, as well as elevated production of tumor necrosis factor (TNF)-a and decreased production of interleukin (IL)-10. Elevated levels of inflammatory cytokines like IL-1 and IL-17 in BD have been found associated with aberrant expression of microRNA. Gene polymorphisms in BD patients have been observed in molecules involved in responses to pathogens that can ultimately modulate the host anti- microbial response. Moreover, several single nucleotide polymorphisms (SNPs) have been reported in genes encoding chemokines and adhesion molecules; many of these changes manifest as increases in vas- cular inflammation and vascular damage. Lastly, genetic and epigenetic changes have been suggested as involved in the pathogenesis of BD. Modifications in DNA methylation have been found in BD patient monocytes and lymphocytes, leading to adverse function of these cells. This review presents a compre- hensive compilation of the literature with regard to the immunodysfunction underlying BD, as well as of the genetics, newly described clinical specifications and novel treatment strategies using immunomodu- lants based on the current understanding of BD.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
آرش سلمانی نژاداول

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Genetics and immunodysfunction underlying Beh et s disease and immunomodulant treatment approaches.pdf1396/05/051593157دانلود